Mutations in the eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4) gene have been linked to the development of PVOD, with the worst prognosis seen in homozygous mutation carriers. This evidence concerns the gene EIF2AK4 and pulmonary venoocclusive disease.